Press Room

Read about MSH presence at the World Health Assembly Provisional agenda item 13.3 – Health systems Addressing the global shortage of, and access to, medicines and vaccines

Geneva, Switzerland – Health stakeholders, experts, and policy makers will join together once again this May at the 70th World Health Assembly (WHA) in Geneva. Management Sciences for Health (MSH) is sponsoring events focused on advancing the Global Health Security Agenda and building stronger and more resilient health systems in fragile environments, especially for women and children. Selected events listed below. Journalists are invited to attend. MSH Position Statements for the 70th World Health Assembly May 21, 2017 – May 27, 2017

As an organization committed to saving lives and improving the health of the world’s poorest and most vulnerable people by strengthening the health systems that serve them, Management Sciences for Health (MSH) is deeply concerned about the impact of the U.S. Government’s defunding of the United Nations Population Fund (UNFPA). The elimination of U.S. funds for UNFPA puts the health and rights of millions of women and children at risk and stands in stark contrast to American values.

Formerly known as the International Drug Price Indicator Guide, the revised publication includes more than 80 non-pharmaceutical products The guide lists medical product prices on the international market An essential reference for anyone involved in the procurement of medical products Essential medicines, vaccines, immunologic agents, disinfectants, fluids and electrolytes, and diagnostic tests and agents are included

SILVER SPRING, Maryland — "The Lucky Specials" is a feature-length film slated to entertain millions in southern Africa and around the world with its dynamic storyline, new brand of African music, and unique look at the global epidemic of tuberculosis (TB).

FREETOWN, Sierra Leone — The National Malaria Control Program (NMCP) in Sierra Leone will conduct a three-day workshop from March 22-24, 2017, to align its vital Malaria in Pregnancy (MIP) guidelines developed in 2005 with its 2016-2020 Malaria Strategic Plan which aims to protect at least 80% of pregnant women and children under one year with Intermittent Preventive Treatment for pregnant women (IPTp3) by 2020  and address the current World Health Organization (WHO) recommendations and Sustainable Development Goals, which look to, in part, reduce global malaria mortality rates

Pages

Printer Friendly Version